New pill aims to fight narcolepsy sleepiness
NCT ID NCT07493265
First seen Apr 06, 2026 · Last updated May 14, 2026 · Updated 2 times
Summary
This study tests an experimental drug called E2086 in 64 adults with narcolepsy to see if it reduces excessive daytime sleepiness and cataplexy (sudden muscle weakness). Participants will receive either E2086 or a placebo for 4 weeks. The main goal is to measure how well they can stay awake using a standard wakefulness test.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NARCOLEPSY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.